A Comparative Phase 2 clinical study to evaluate efficacy of Kantakaryadi Kwatha and Bhunimbadi Kwatha in Urdhavag Amlapitta

In modern era amlapitta is a most remarkable problem in the society it is a very common disease mostly affecting the adult men and women in the Indian population As the treatment the use of antacids which has symptomatic relief only Antacids that contain aluminum hydroxide may causeconstipationaluminum intoxication osteomalacia and hypophosphatemia  Kantakaryadi kwatha is a drug of choice for Amlapitta contain all the necessary ingredients that are useful to breakdown pathophysiology of Amlapitta by their rasa and virya properties   Kantakaryadi kwatha will be preparaed as per reference mentioned in ayurvedic text under supervision of experts in Dept. Of Rasashastra & Bhaishajyakalpana of Ayurved Seva Sangh College Nashik  and Bhunumbadi Kwatha is a drug of choice for parallel study It is prepared by a GMP certified Ayurvedic drug manufacturing company The clinical study to evaluate the efficacy of these drugs will be beneficial to the practitioners of Ayurveda throughtout the world so here study is designed to evaluate the efficacy of Kantakaryadi Kwatha internally twice a daily for 21 days and Bhunimbadi Kwatha internally twice a daily for 21 days in the management of Amlapitta